How big is the ngs tumor gene analysis software market?

According to QYResearch’s new survey, global NGS Tumor Gene Analysis Software market is projected to reach US$ 4644.9 million in 2029, increasing from US$ 1509 million in 2022, with the CAGR of 17.5% during the period of 2023 to 2029.

NGS Tumor Gene Analysis Software Market

NGS (Next-Generation Sequencing) tumor gene analysis software refers to computer programs and tools designed to analyze genomic data obtained from the sequencing of tumor samples using next-generation sequencing technologies. These software applications are specifically developed to process and interpret the vast amount of genetic information generated by NGS platforms, allowing researchers and clinicians to identify genetic variants, mutations, and other genomic alterations associated with tumors.

Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole NGS Tumor Gene Analysis Software market research.

Key companies engaged in the NGS Tumor Gene Analysis Software industry include Roche, Illumina, Thermo Fisher Scientific, BGI Group, Novogene, Geneseeq, AmoyDx, Burning Rock Medicine and GTH.O, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.

When refers to consumption region, % value of NGS Tumor Gene Analysis Software were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole NGS Tumor Gene Analysis Software market and estimated to attract more attentions from industry insiders and investors.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global NGS Tumor Gene Analysis Software market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

Scope of NGS Tumor Gene Analysis Software Market Report

Report Metric	Details
Report Name	NGS Tumor Gene Analysis Software Market
Accounted market size in 2022	US$ 1509 million
Forecasted market size in 2029	US$ 4644.9 million
CAGR	17.5%
Base Year	2022
Forecasted years	2023 - 2029
Segment by Type	Non-Small Cell Lung Cancer Human 6 Gene Mutations Human 12 Gene Mutations Other
Segment by Application	Hospitals and Health Systems Research Institute Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Roche, Illumina, Thermo Fisher Scientific, BGI Group, Novogene, Geneseeq, AmoyDx, Burning Rock Medicine, GTH.O, Golden Helix, Inc, Diatech Pharmacogenetics, ViennaLab Diagnostics GmbH, 3D Medicines
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

FAQ for this report

How fast is NGS Tumor Gene Analysis Software Market market growing?

Ans: The NGS Tumor Gene Analysis Software Market market witnessing a CAGR of 17.5% during the forecast period 2023-2029.

What is the NGS Tumor Gene Analysis Software Market market size in 2029?

Ans: According to QYResearch’s new survey, global NGS Tumor Gene Analysis Software market is projected to reach US$ 4644.9 million in 2029, increasing from US$ 1509 million in 2022, with the CAGR of 17.5% during the period of 2023 to 2029.

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global NGS Tumor Gene Analysis Software Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 Non-Small Cell Lung Cancer

1.2.3 Human 6 Gene Mutations

1.2.4 Human 12 Gene Mutations

1.2.5 Other

1.3 Market by Application

1.3.1 Global NGS Tumor Gene Analysis Software Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Hospitals and Health Systems

1.3.3 Research Institute

1.3.4 Other

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global NGS Tumor Gene Analysis Software Market Perspective (2018-2029)

2.2 NGS Tumor Gene Analysis Software Growth Trends by Region

2.2.1 Global NGS Tumor Gene Analysis Software Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 NGS Tumor Gene Analysis Software Historic Market Size by Region (2018-2023)

2.2.3 NGS Tumor Gene Analysis Software Forecasted Market Size by Region (2024-2029)

2.3 NGS Tumor Gene Analysis Software Market Dynamics

2.3.1 NGS Tumor Gene Analysis Software Industry Trends

2.3.2 NGS Tumor Gene Analysis Software Market Drivers

2.3.3 NGS Tumor Gene Analysis Software Market Challenges

2.3.4 NGS Tumor Gene Analysis Software Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top NGS Tumor Gene Analysis Software Players by Revenue

3.1.1 Global Top NGS Tumor Gene Analysis Software Players by Revenue (2018-2023)

3.1.2 Global NGS Tumor Gene Analysis Software Revenue Market Share by Players (2018-2023)

3.2 Global NGS Tumor Gene Analysis Software Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by NGS Tumor Gene Analysis Software Revenue

3.4 Global NGS Tumor Gene Analysis Software Market Concentration Ratio

3.4.1 Global NGS Tumor Gene Analysis Software Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by NGS Tumor Gene Analysis Software Revenue in 2022

3.5 NGS Tumor Gene Analysis Software Key Players Head office and Area Served

3.6 Key Players NGS Tumor Gene Analysis Software Product Solution and Service

3.7 Date of Enter into NGS Tumor Gene Analysis Software Market

3.8 Mergers & Acquisitions, Expansion Plans

4 NGS Tumor Gene Analysis Software Breakdown Data by Type

4.1 Global NGS Tumor Gene Analysis Software Historic Market Size by Type (2018-2023)

4.2 Global NGS Tumor Gene Analysis Software Forecasted Market Size by Type (2024-2029)

5 NGS Tumor Gene Analysis Software Breakdown Data by Application

5.1 Global NGS Tumor Gene Analysis Software Historic Market Size by Application (2018-2023)

5.2 Global NGS Tumor Gene Analysis Software Forecasted Market Size by Application (2024-2029)

6 North America

6.1 North America NGS Tumor Gene Analysis Software Market Size (2018-2029)

6.2 North America NGS Tumor Gene Analysis Software Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America NGS Tumor Gene Analysis Software Market Size by Country (2018-2023)

6.4 North America NGS Tumor Gene Analysis Software Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe NGS Tumor Gene Analysis Software Market Size (2018-2029)

7.2 Europe NGS Tumor Gene Analysis Software Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe NGS Tumor Gene Analysis Software Market Size by Country (2018-2023)

7.4 Europe NGS Tumor Gene Analysis Software Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific NGS Tumor Gene Analysis Software Market Size (2018-2029)

8.2 Asia-Pacific NGS Tumor Gene Analysis Software Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific NGS Tumor Gene Analysis Software Market Size by Region (2018-2023)

8.4 Asia-Pacific NGS Tumor Gene Analysis Software Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America NGS Tumor Gene Analysis Software Market Size (2018-2029)

9.2 Latin America NGS Tumor Gene Analysis Software Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America NGS Tumor Gene Analysis Software Market Size by Country (2018-2023)

9.4 Latin America NGS Tumor Gene Analysis Software Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa NGS Tumor Gene Analysis Software Market Size (2018-2029)

10.2 Middle East & Africa NGS Tumor Gene Analysis Software Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa NGS Tumor Gene Analysis Software Market Size by Country (2018-2023)

10.4 Middle East & Africa NGS Tumor Gene Analysis Software Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Roche

11.1.1 Roche Company Detail

11.1.2 Roche Business Overview

11.1.3 Roche NGS Tumor Gene Analysis Software Introduction

11.1.4 Roche Revenue in NGS Tumor Gene Analysis Software Business (2018-2023)

11.1.5 Roche Recent Development

11.2 Illumina

11.2.1 Illumina Company Detail

11.2.2 Illumina Business Overview

11.2.3 Illumina NGS Tumor Gene Analysis Software Introduction

11.2.4 Illumina Revenue in NGS Tumor Gene Analysis Software Business (2018-2023)

11.2.5 Illumina Recent Development

11.3 Thermo Fisher Scientific

11.3.1 Thermo Fisher Scientific Company Detail

11.3.2 Thermo Fisher Scientific Business Overview

11.3.3 Thermo Fisher Scientific NGS Tumor Gene Analysis Software Introduction

11.3.4 Thermo Fisher Scientific Revenue in NGS Tumor Gene Analysis Software Business (2018-2023)

11.3.5 Thermo Fisher Scientific Recent Development

11.4 BGI Group

11.4.1 BGI Group Company Detail

11.4.2 BGI Group Business Overview

11.4.3 BGI Group NGS Tumor Gene Analysis Software Introduction

11.4.4 BGI Group Revenue in NGS Tumor Gene Analysis Software Business (2018-2023)

11.4.5 BGI Group Recent Development

11.5 Novogene

11.5.1 Novogene Company Detail

11.5.2 Novogene Business Overview

11.5.3 Novogene NGS Tumor Gene Analysis Software Introduction

11.5.4 Novogene Revenue in NGS Tumor Gene Analysis Software Business (2018-2023)

11.5.5 Novogene Recent Development

11.6 Geneseeq

11.6.1 Geneseeq Company Detail

11.6.2 Geneseeq Business Overview

11.6.3 Geneseeq NGS Tumor Gene Analysis Software Introduction

11.6.4 Geneseeq Revenue in NGS Tumor Gene Analysis Software Business (2018-2023)

11.6.5 Geneseeq Recent Development

11.7 AmoyDx

11.7.1 AmoyDx Company Detail

11.7.2 AmoyDx Business Overview

11.7.3 AmoyDx NGS Tumor Gene Analysis Software Introduction

11.7.4 AmoyDx Revenue in NGS Tumor Gene Analysis Software Business (2018-2023)

11.7.5 AmoyDx Recent Development

11.8 Burning Rock Medicine

11.8.1 Burning Rock Medicine Company Detail

11.8.2 Burning Rock Medicine Business Overview

11.8.3 Burning Rock Medicine NGS Tumor Gene Analysis Software Introduction

11.8.4 Burning Rock Medicine Revenue in NGS Tumor Gene Analysis Software Business (2018-2023)

11.8.5 Burning Rock Medicine Recent Development

11.9 GTH.O

11.9.1 GTH.O Company Detail

11.9.2 GTH.O Business Overview

11.9.3 GTH.O NGS Tumor Gene Analysis Software Introduction

11.9.4 GTH.O Revenue in NGS Tumor Gene Analysis Software Business (2018-2023)

11.9.5 GTH.O Recent Development

11.10 Golden Helix, Inc

11.10.1 Golden Helix, Inc Company Detail

11.10.2 Golden Helix, Inc Business Overview

11.10.3 Golden Helix, Inc NGS Tumor Gene Analysis Software Introduction

11.10.4 Golden Helix, Inc Revenue in NGS Tumor Gene Analysis Software Business (2018-2023)

11.10.5 Golden Helix, Inc Recent Development

11.11 Diatech Pharmacogenetics

11.11.1 Diatech Pharmacogenetics Company Detail

11.11.2 Diatech Pharmacogenetics Business Overview

11.11.3 Diatech Pharmacogenetics NGS Tumor Gene Analysis Software Introduction

11.11.4 Diatech Pharmacogenetics Revenue in NGS Tumor Gene Analysis Software Business (2018-2023)

11.11.5 Diatech Pharmacogenetics Recent Development

11.12 ViennaLab Diagnostics GmbH

11.12.1 ViennaLab Diagnostics GmbH Company Detail

11.12.2 ViennaLab Diagnostics GmbH Business Overview

11.12.3 ViennaLab Diagnostics GmbH NGS Tumor Gene Analysis Software Introduction

11.12.4 ViennaLab Diagnostics GmbH Revenue in NGS Tumor Gene Analysis Software Business (2018-2023)

11.12.5 ViennaLab Diagnostics GmbH Recent Development

11.13 3D Medicines

11.13.1 3D Medicines Company Detail

11.13.2 3D Medicines Business Overview

11.13.3 3D Medicines NGS Tumor Gene Analysis Software Introduction

11.13.4 3D Medicines Revenue in NGS Tumor Gene Analysis Software Business (2018-2023)

11.13.5 3D Medicines Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

NGS

Roche

Illumina Inc

Thermo Fisher Scientific

Burning Rock Medicine

GTH.O

Golden Helix, Inc.

3D Medicines

Diatech Pharmacogenetics

ViennaLab Diagnostics GmbH

List of Tables

Table 1. Global NGS Tumor Gene Analysis Software Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

Table 2. Key Players of Non-Small Cell Lung Cancer

Table 3. Key Players of Human 6 Gene Mutations

Table 4. Key Players of Human 12 Gene Mutations

Table 5. Key Players of Other

Table 6. Global NGS Tumor Gene Analysis Software Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

Table 7. Global NGS Tumor Gene Analysis Software Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

Table 8. Global NGS Tumor Gene Analysis Software Market Size by Region (2018-2023) & (US$ Million)

Table 9. Global NGS Tumor Gene Analysis Software Market Share by Region (2018-2023)

Table 10. Global NGS Tumor Gene Analysis Software Forecasted Market Size by Region (2024-2029) & (US$ Million)

Table 11. Global NGS Tumor Gene Analysis Software Market Share by Region (2024-2029)

Table 12. NGS Tumor Gene Analysis Software Market Trends

Table 13. NGS Tumor Gene Analysis Software Market Drivers

Table 14. NGS Tumor Gene Analysis Software Market Challenges

Table 15. NGS Tumor Gene Analysis Software Market Restraints

Table 16. Global NGS Tumor Gene Analysis Software Revenue by Players (2018-2023) & (US$ Million)

Table 17. Global NGS Tumor Gene Analysis Software Market Share by Players (2018-2023)

Table 18. Global Top NGS Tumor Gene Analysis Software Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NGS Tumor Gene Analysis Software as of 2022)

Table 19. Ranking of Global Top NGS Tumor Gene Analysis Software Companies by Revenue (US$ Million) in 2022

Table 20. Global 5 Largest Players Market Share by NGS Tumor Gene Analysis Software Revenue (CR5 and HHI) & (2018-2023)

Table 21. Key Players Headquarters and Area Served

Table 22. Key Players NGS Tumor Gene Analysis Software Product Solution and Service

Table 23. Date of Enter into NGS Tumor Gene Analysis Software Market

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global NGS Tumor Gene Analysis Software Market Size by Type (2018-2023) & (US$ Million)

Table 26. Global NGS Tumor Gene Analysis Software Revenue Market Share by Type (2018-2023)

Table 27. Global NGS Tumor Gene Analysis Software Forecasted Market Size by Type (2024-2029) & (US$ Million)

Table 28. Global NGS Tumor Gene Analysis Software Revenue Market Share by Type (2024-2029)

Table 29. Global NGS Tumor Gene Analysis Software Market Size by Application (2018-2023) & (US$ Million)

Table 30. Global NGS Tumor Gene Analysis Software Revenue Market Share by Application (2018-2023)

Table 31. Global NGS Tumor Gene Analysis Software Forecasted Market Size by Application (2024-2029) & (US$ Million)

Table 32. Global NGS Tumor Gene Analysis Software Revenue Market Share by Application (2024-2029)

Table 33. North America NGS Tumor Gene Analysis Software Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

Table 34. North America NGS Tumor Gene Analysis Software Market Size by Country (2018-2023) & (US$ Million)

Table 35. North America NGS Tumor Gene Analysis Software Market Size by Country (2024-2029) & (US$ Million)

Table 36. Europe NGS Tumor Gene Analysis Software Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

Table 37. Europe NGS Tumor Gene Analysis Software Market Size by Country (2018-2023) & (US$ Million)

Table 38. Europe NGS Tumor Gene Analysis Software Market Size by Country (2024-2029) & (US$ Million)

Table 39. Asia-Pacific NGS Tumor Gene Analysis Software Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

Table 40. Asia-Pacific NGS Tumor Gene Analysis Software Market Size by Region (2018-2023) & (US$ Million)

Table 41. Asia-Pacific NGS Tumor Gene Analysis Software Market Size by Region (2024-2029) & (US$ Million)

Table 42. Latin America NGS Tumor Gene Analysis Software Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

Table 43. Latin America NGS Tumor Gene Analysis Software Market Size by Country (2018-2023) & (US$ Million)

Table 44. Latin America NGS Tumor Gene Analysis Software Market Size by Country (2024-2029) & (US$ Million)

Table 45. Middle East & Africa NGS Tumor Gene Analysis Software Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

Table 46. Middle East & Africa NGS Tumor Gene Analysis Software Market Size by Country (2018-2023) & (US$ Million)

Table 47. Middle East & Africa NGS Tumor Gene Analysis Software Market Size by Country (2024-2029) & (US$ Million)

Table 48. Roche Company Detail

Table 49. Roche Business Overview

Table 50. Roche NGS Tumor Gene Analysis Software Product

Table 51. Roche Revenue in NGS Tumor Gene Analysis Software Business (2018-2023) & (US$ Million)

Table 52. Roche Recent Development

Table 53. Illumina Company Detail

Table 54. Illumina Business Overview

Table 55. Illumina NGS Tumor Gene Analysis Software Product

Table 56. Illumina Revenue in NGS Tumor Gene Analysis Software Business (2018-2023) & (US$ Million)

Table 57. Illumina Recent Development

Table 58. Thermo Fisher Scientific Company Detail

Table 59. Thermo Fisher Scientific Business Overview

Table 60. Thermo Fisher Scientific NGS Tumor Gene Analysis Software Product

Table 61. Thermo Fisher Scientific Revenue in NGS Tumor Gene Analysis Software Business (2018-2023) & (US$ Million)

Table 62. Thermo Fisher Scientific Recent Development

Table 63. BGI Group Company Detail

Table 64. BGI Group Business Overview

Table 65. BGI Group NGS Tumor Gene Analysis Software Product

Table 66. BGI Group Revenue in NGS Tumor Gene Analysis Software Business (2018-2023) & (US$ Million)

Table 67. BGI Group Recent Development

Table 68. Novogene Company Detail

Table 69. Novogene Business Overview

Table 70. Novogene NGS Tumor Gene Analysis Software Product

Table 71. Novogene Revenue in NGS Tumor Gene Analysis Software Business (2018-2023) & (US$ Million)

Table 72. Novogene Recent Development

Table 73. Geneseeq Company Detail

Table 74. Geneseeq Business Overview

Table 75. Geneseeq NGS Tumor Gene Analysis Software Product

Table 76. Geneseeq Revenue in NGS Tumor Gene Analysis Software Business (2018-2023) & (US$ Million)

Table 77. Geneseeq Recent Development

Table 78. AmoyDx Company Detail

Table 79. AmoyDx Business Overview

Table 80. AmoyDx NGS Tumor Gene Analysis Software Product

Table 81. AmoyDx Revenue in NGS Tumor Gene Analysis Software Business (2018-2023) & (US$ Million)

Table 82. AmoyDx Recent Development

Table 83. Burning Rock Medicine Company Detail

Table 84. Burning Rock Medicine Business Overview

Table 85. Burning Rock Medicine NGS Tumor Gene Analysis Software Product

Table 86. Burning Rock Medicine Revenue in NGS Tumor Gene Analysis Software Business (2018-2023) & (US$ Million)

Table 87. Burning Rock Medicine Recent Development

Table 88. GTH.O Company Detail

Table 89. GTH.O Business Overview

Table 90. GTH.O NGS Tumor Gene Analysis Software Product

Table 91. GTH.O Revenue in NGS Tumor Gene Analysis Software Business (2018-2023) & (US$ Million)

Table 92. GTH.O Recent Development

Table 93. Golden Helix, Inc Company Detail

Table 94. Golden Helix, Inc Business Overview

Table 95. Golden Helix, Inc NGS Tumor Gene Analysis Software Product

Table 96. Golden Helix, Inc Revenue in NGS Tumor Gene Analysis Software Business (2018-2023) & (US$ Million)

Table 97. Golden Helix, Inc Recent Development

Table 98. Diatech Pharmacogenetics Company Detail

Table 99. Diatech Pharmacogenetics Business Overview

Table 100. Diatech Pharmacogenetics NGS Tumor Gene Analysis Software Product

Table 101. Diatech Pharmacogenetics Revenue in NGS Tumor Gene Analysis Software Business (2018-2023) & (US$ Million)

Table 102. Diatech Pharmacogenetics Recent Development

Table 103. ViennaLab Diagnostics GmbH Company Detail

Table 104. ViennaLab Diagnostics GmbH Business Overview

Table 105. ViennaLab Diagnostics GmbH NGS Tumor Gene Analysis Software Product

Table 106. ViennaLab Diagnostics GmbH Revenue in NGS Tumor Gene Analysis Software Business (2018-2023) & (US$ Million)

Table 107. ViennaLab Diagnostics GmbH Recent Development

Table 108. 3D Medicines Company Detail

Table 109. 3D Medicines Business Overview

Table 110. 3D Medicines NGS Tumor Gene Analysis Software Product

Table 111. 3D Medicines Revenue in NGS Tumor Gene Analysis Software Business (2018-2023) & (US$ Million)

Table 112. 3D Medicines Recent Development

Table 113. Research Programs/Design for This Report

Table 114. Key Data Information from Secondary Sources

Table 115. Key Data Information from Primary Sources

List of Figures

Figure 1. Global NGS Tumor Gene Analysis Software Market Size Comparison by Type (2023-2029) & (US$ Million)

Figure 2. Global NGS Tumor Gene Analysis Software Market Share by Type: 2022 VS 2029

Figure 3. Non-Small Cell Lung Cancer Features

Figure 4. Human 6 Gene Mutations Features

Figure 5. Human 12 Gene Mutations Features

Figure 6. Other Features

Figure 7. Global NGS Tumor Gene Analysis Software Market Size Comparison by Application (2023-2029) & (US$ Million)

Figure 8. Global NGS Tumor Gene Analysis Software Market Share by Application: 2022 VS 2029

Figure 9. Hospitals and Health Systems Case Studies

Figure 10. Research Institute Case Studies

Figure 11. Other Case Studies

Figure 12. NGS Tumor Gene Analysis Software Report Years Considered

Figure 13. Global NGS Tumor Gene Analysis Software Market Size (US$ Million), Year-over-Year: 2018-2029

Figure 14. Global NGS Tumor Gene Analysis Software Market Size, (US$ Million), 2018 VS 2022 VS 2029

Figure 15. Global NGS Tumor Gene Analysis Software Market Share by Region: 2022 VS 2029

Figure 16. Global NGS Tumor Gene Analysis Software Market Share by Players in 2022

Figure 17. Global Top NGS Tumor Gene Analysis Software Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NGS Tumor Gene Analysis Software as of 2022)

Figure 18. The Top 10 and 5 Players Market Share by NGS Tumor Gene Analysis Software Revenue in 2022

Figure 19. North America NGS Tumor Gene Analysis Software Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 20. North America NGS Tumor Gene Analysis Software Market Share by Country (2018-2029)

Figure 21. United States NGS Tumor Gene Analysis Software Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 22. Canada NGS Tumor Gene Analysis Software Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 23. Europe NGS Tumor Gene Analysis Software Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 24. Europe NGS Tumor Gene Analysis Software Market Share by Country (2018-2029)

Figure 25. Germany NGS Tumor Gene Analysis Software Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 26. France NGS Tumor Gene Analysis Software Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 27. U.K. NGS Tumor Gene Analysis Software Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 28. Italy NGS Tumor Gene Analysis Software Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 29. Russia NGS Tumor Gene Analysis Software Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 30. Nordic Countries NGS Tumor Gene Analysis Software Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 31. Asia-Pacific NGS Tumor Gene Analysis Software Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 32. Asia-Pacific NGS Tumor Gene Analysis Software Market Share by Region (2018-2029)

Figure 33. China NGS Tumor Gene Analysis Software Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 34. Japan NGS Tumor Gene Analysis Software Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 35. South Korea NGS Tumor Gene Analysis Software Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 36. Southeast Asia NGS Tumor Gene Analysis Software Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 37. India NGS Tumor Gene Analysis Software Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 38. Australia NGS Tumor Gene Analysis Software Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 39. Latin America NGS Tumor Gene Analysis Software Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 40. Latin America NGS Tumor Gene Analysis Software Market Share by Country (2018-2029)

Figure 41. Mexico NGS Tumor Gene Analysis Software Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 42. Brazil NGS Tumor Gene Analysis Software Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 43. Middle East & Africa NGS Tumor Gene Analysis Software Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 44. Middle East & Africa NGS Tumor Gene Analysis Software Market Share by Country (2018-2029)

Figure 45. Turkey NGS Tumor Gene Analysis Software Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 46. Saudi Arabia NGS Tumor Gene Analysis Software Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 47. Roche Revenue Growth Rate in NGS Tumor Gene Analysis Software Business (2018-2023)

Figure 48. Illumina Revenue Growth Rate in NGS Tumor Gene Analysis Software Business (2018-2023)

Figure 49. Thermo Fisher Scientific Revenue Growth Rate in NGS Tumor Gene Analysis Software Business (2018-2023)

Figure 50. BGI Group Revenue Growth Rate in NGS Tumor Gene Analysis Software Business (2018-2023)

Figure 51. Novogene Revenue Growth Rate in NGS Tumor Gene Analysis Software Business (2018-2023)

Figure 52. Geneseeq Revenue Growth Rate in NGS Tumor Gene Analysis Software Business (2018-2023)

Figure 53. AmoyDx Revenue Growth Rate in NGS Tumor Gene Analysis Software Business (2018-2023)

Figure 54. Burning Rock Medicine Revenue Growth Rate in NGS Tumor Gene Analysis Software Business (2018-2023)

Figure 55. GTH.O Revenue Growth Rate in NGS Tumor Gene Analysis Software Business (2018-2023)

Figure 56. Golden Helix, Inc Revenue Growth Rate in NGS Tumor Gene Analysis Software Business (2018-2023)

Figure 57. Diatech Pharmacogenetics Revenue Growth Rate in NGS Tumor Gene Analysis Software Business (2018-2023)

Figure 58. ViennaLab Diagnostics GmbH Revenue Growth Rate in NGS Tumor Gene Analysis Software Business (2018-2023)

Figure 59. 3D Medicines Revenue Growth Rate in NGS Tumor Gene Analysis Software Business (2018-2023)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

Global NGS Tumor Gene Analysis Software Market Research Report 2023

Published Date: August 2023

Report Code: QYRE-Auto-1U15180

Global NGS Tumor Gene Analysis Software Market Research Report 2023

FEATURED COMPANIES

NGS Tumor Gene Analysis Software Market Size

NGS Tumor Gene Analysis Software Market

Report Scope

Scope of NGS Tumor Gene Analysis Software Market Report

FAQ for this report

How fast is NGS Tumor Gene Analysis Software Market market growing?

What is the NGS Tumor Gene Analysis Software Market market size in 2029?

FEATURED COMPANIES

RELATED REPORTS